Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits. 1981

E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil

The pharmacokinetics of 7-[D-(-)-alpha-amino-alpha-(4-hydroxyphenyl)-acetamido]-3-methyl-3-cefen-4-carboxylic acid (cefadroxil) were studied in rabbits with normal renal function and with varying degrees of experimentally caused renal impairment. All the animals included in the survey received a single i.v. dose of 30 mg/kg of the antibiotic. The following variations may be observed in the parameters established for the rabbits with altered renal function with respect to the rabbits with normal renal function: alpha, beta,K12, K21, K13, Vc and Vp decrease, and t 1/2 alpha, t 1/2 beta, and (AUC) infinity o increase. Linear relationships are established between the plasma urea and creatinine values, indices of the degree of renal function, and log k13. There is an increase in biliary excretion in rabbits with renal impairment and a linear relationship between the percentage of the antibiotic excreted and the plasma urea and a creatinine values. In rabbits with normal renal function a linear relationship may be found between the elimination rate of the drug in urine and the plasma concentration of the antibiotic.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002434 Cefadroxil Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative. 4-Hydroxycephalexin,5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,BL-S 578,BL-S578,Bidocef,Cefadroxil Anhydrous,Cefadroxil Monohydrate,Cephadroxyl,Duricef,S-578,S578,Ultracef,4 Hydroxycephalexin,BL S 578,BL S578,BLS 578,BLS578,S 578
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
March 1980, The Journal of antibiotics,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
January 1981, Biopharmaceutics & drug disposition,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
January 2014, BioMed research international,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
January 1997, Clinical pharmacokinetics,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
March 1988, Clinical pharmacology and therapeutics,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
September 2007, British journal of clinical pharmacology,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
January 2012, Journal of pharmacological sciences,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
September 1982, The Journal of antimicrobial chemotherapy,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
July 1972, Toxicology and applied pharmacology,
E L Mariño, and A A Dominguez-Gil, and M Cepeda, and M J Otero, and A Dominguez-Gil
January 1999, Clinical pharmacokinetics,
Copied contents to your clipboard!